A Study to Investigate the Effect of Bupivacaine Liposomal Injectable Suspension on Hospital Costs, Length of Stay, and Discharge Status in Patients Undergoing Total Knee Arthroplasty at High Use Institutions
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2018
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 09 Dec 2018 New trial record
- 27 Nov 2018 According to a Pacira Pharmaceuticals media release, results of this study were published in The Journal of Medical Economics.
- 27 Nov 2018 New results from this study presented in a Pacira Pharmaceuticals media release.